Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fasted Conditions

The requested reference [d6ba80187d06656362e4544bfe43e58cc50878b8] no longer exists in our database. It has been replaced by the current reference: [b0a8a94f1620dcd6b184e40428e1d5ed76a3776c]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The objective of this study was to prove the bioequivalence of Roxane Laboratories\' Quetiapine Fumarate 25 mg Tablet under fasted conditions.
Epistemonikos ID: 918d038f7462116ead5ef68c70cb53272c76fba8
First added on: May 10, 2024